ENHERTU® Showed Clinically Meaningful and Durable Responses Across Multiple HER2 Expressing Tumor Types in DESTINY-PanTumor02 Phase 2 Trial
Daiichi Sankyo and AstraZeneca’s ENHERTU met pre-specified criteria for objective response rate and duration of response TOKYO & BASKING RIDGE,...

CNBC Awaaz goes live on DistroTV as Network18 expands free streaming
Democratic Midterm Victories Trigger Slump in Trump Media Shares and Crypto Tokens
Rain-Abandoned Fifth T20I Leaves India vs West Indies Series Tied 2-2
Adani’s Mumbai airport takeover is less about one airport than about control of MIAL
DIPAM Valuation Shift Triggers Backlash Over $5.5 Billion IDBI Bank Takeover 

























